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Abstract: Background: Obesity increases the risk of many health complications such as hypertension, coronary heart dis-
ease and type 2 diabetes, needs long-lasting treatment for effective results and involves high public and private care-costs. 
Therefore, it is imperative that enduring and low-cost clinical programs for obesity and related co-morbidities are devel-
oped and evaluated. Information and communication technologies (ICT) can help clinicians to deliver treatment in a cost-
effective and time-saving manner to a large number of obese individuals with co-morbidities.  
Objective: To examine ad interim effectiveness of a 12-month multidisciplinary telecare intervention for weight loss pro-
vided to obese patients with type 2 diabetes. 
Design, Setting, and Participants: A single-center randomized controlled trial (TECNOB study) started in December 
2008. At present, 72 obese patients with type 2 diabetes have been recruited and randomly allocated to the TECNOB pro-
gram (n=37) or to a control condition (n=39). However, only 34 participants have completed at least the 3-month follow-
up and have been included in this ad interim analysis. 21 out of them have reached also the 6-month follow-up and 13 
have achieved the end of the program. Study is still on-going.  
Intervention: All participants attended 1-month inpatient intensive program that involved individualized medical care, diet 
therapy, physical training and brief psychological counseling. At discharge, participants allocated to the TECNOB pro-
gram were instructed to use a weight-loss web-site, a web-based videoconference tool, a dietary software installed into 
their cellular phones and an electronic armband measuring daily steps and energy expenditure.  
Main Outcome Measures: Weight and disordered eating-related behaviors and cognitions (EDI-2) at entry to hospital, at 
discharge from hospital, at 3,6 and 12 months.  
Results: Ad interim analysis of data from 34 participants showed no statistically significant difference between groups in 
weight change at any time-point. However, within-group analysis revealed significant reductions of initial weight at dis-
charge from hospital, at 3 months, at 6 months but not at 12 months. Control group had higher scores in Interpersonal dis-
trust at 12 months. 
Conclusion: This ad interim findings revealed that the effect of the inpatient treatment was high and probably over-
whelmed the effect of the TECNOB intervention. Much statistical power and long-term follow-up may enhance the prob-
ability to detect the TECNOB effect over and above the great one exerted by the inpatient program.  
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BACKGROUND 
Obesity is a condition with such an increasing prevalence 
that it can be defined as a global epidemic. In 2005, about  
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1.6 billion adults (above 15 years of age) were estimated to 
be overweight, whereas about 400 million people were 
obese. WHO further projects that by 2015, approximately 
2.3 billion adults will be overweight and more than 700 mil-
lion will be obese [1]. Obesity increases the risk of many 
health complications such as cardiovascular diseases, some 
types of cancer, osteoarthritis, hypertension, dyslipidemia, 
and hypercholesterolemia, and is associated with early death 
[2, 3]. Obesity is a strong risk factor for the development of TECNOB Study: Ad Interim Results  Clinical Practice & Epidemiology in Mental Health, 2011, Volume 7    45 
type II diabetes [4, 5]. Indeed, as BMI (Body Mass Index) 
increases, the risk of developing type 2 diabetes
 increases in 
a "dose-dependent" manner [6, 7]. The prevalence of type 2 
diabetes is 3–7 times higher in obese than in normal-weight 
adults, and those with a BMI >35 are 20 times more likely to 
develop type 2 diabetes than those with a BMI between 18.5 
and 24.9 [8, 9].  
Obesity-related medical complications weigh heavily on 
public health care costs and developing effective interven-
tions for substantially reduce weight, maintain weight loss 
and prevent or manage associated diseases like type 2 diabe-
tes in cost-effective manner is a priority.  
Stand-alone and combined treatment options (dietetic, 
nutritional, physical, behavioral, cognitive-behavioral, phar-
macological, surgical) are available, but clinical practice and 
research have shown significant difficulties with regard to 
availability, costs, treatment adherence and long-term effi-
cacy [10]. These procedures imply high costs both for the 
obese individuals and the public health system, overall 
within an enduring care setting. Indeed, the main challenge 
in the treatment of obesity is to maintain weight loss in the 
long term [11]. Most overweight and obese individuals re-
gain about one third of the weight lost with treatment within 
1 year, sometimes even before the end of the intervention, 
and they are typically back to baseline in 3 to 5 years [12-
14]. Similarly, few patients with diabetes go on taking their 
prescribed medication entirely as intended [15, 16].  
Continuous and cost-effective approaches that can reach 
a large number of obese individuals are thus needed. A new 
promising method for granting continuity of care to wide 
populations of patients at low costs is telemedicine and its 
more specific branches called “e-therapy”, “telecare” and “e-
health”: information and communication technologies (ICT) 
used in order to exchange information useful for the diagno-
sis, treatment, rehabilitation and prevention of diseases [17, 
18]. Telecare can be carried out with tools such as web-sites, 
e-mail, chat lines, videoconference, telephone and mobile 
phones [19]. As already indicated in several studies [20-24] 
and in various reviews[10, 25, 26], behavioral treatments 
delivered through the internet (web-site and e-mail) may be 
valid alternatives to reduce expensive and time-consuming 
clinical visits.  
However, much more work remains to be carried out in 
order to confirm these findings. Furthermore, very few stud-
ies have investigated the effects of an ICT-based program on 
obese patients with established type 2 diabetes and to our 
knowledge no study has tested a comprehensive long-term 
stepped down intervention starting with 1-month hospitaliza-
tion specifically addressed to weight loss. Thus, we planned 
to test the effectiveness of a 12-month multidisciplinary tele-
care intervention for weight loss in comparison with a con-
trol condition. Study is still ongoing and ad interim results 
were reported in this paper.  
MATERIALS AND METHODOLOGY 
Study Sample 
At present, 72 adult obese patients with a mean age of 
53,3 ± 8,4 years, a mean weight of 120,25 ± 20,8 kg and 
type-2 diabetes mellitus have been recruited by research as-
sistants at admission to a 1-month inpatient program for 
weight loss and medical care. Potential participants have 
been identified from notice given by physicians after they 
established a type-2 diabetes mellitus diagnosis. Further in-
clusion criteria were age between 18 and 65 years old, a 
body mass index (BMI)  30, basic knowledge of informat-
ics and home access to a computer with Internet service. 
Moreover, patients had to be free of severe psychiatric dis-
turbances diagnosed by DSM-fourth revised criteria and 
concurrent medical conditions not related to obesity. Eligible 
candidates were scheduled for a 1-hour interview with a 
clinical psychologist during which their psychosocial status 
was assessed, weight and dieting histories were reviewed, 
study details were described and informed consent was ob-
tained.  
At present, only 34 patients have completed the 3-month 
follow-up and have been considered for this first ad interim 
analysis. 21 patients out of them have come through the 6-
month follow-up and 12 have achieved the end of program 
(12-month follow-up). 23 patients out of 72 have been lost at 
3-month follow-up because of many reasons such as surgery, 
house transfer, repeated loss of mailed questionnaires, criti-
cal life-events, motivation loss, etc.  
Study Design 
A detailed description of the study protocol is available 
elsewhere [27]. Briefly, eligible patients who accepted par-
ticipation were randomly assigned according to simple ran-
domization procedures (computerized random numbers) to 
the TECNOB program or to a control condition. Participants 
were seen at baseline and at discharge from hospital for ob-
jective measurement of weight and questionnaires admini-
stration. Follow-up assessments at 3, 6 and 12 months were 
self-reported. All participants attended 1-month inpatient 
program for weight loss and medical care. Before discharge, 
participants allocated to the TECNOB group were instructed 
to use a weight-loss web-site, a dietary software installed 
into their cellular phones, a web-based videoconference tool 
and an electronic armband measuring daily steps and energy 
expenditure. To protect confidentiality, the web-site was 
password protected and participants were given a login iden-
tification code. Patients assigned to control group did not 
receive any instructions and were discharged as all the other 
inpatients not included in the study.  
The research protocol was approved by the institutional 
review board at Istituto Auxologico Italiano, Italy. 
Program Description 
The TECNOB (TEChnology for OBesity) program is a 
comprehensive two-phase stepped down intervention en-
hanced by telecare for the long-term treatment of obese peo-
ple with type 2 diabetes seeking treatment for weight loss 
[28]. The core aspects of TECNOB are the inpatient inten-
sive treatment and the continuity of care at home using new 
information and communication technologies (ICT) such as 
internet and mobile phones.  
The TECNOB clinical program has a total duration of 13 
months and consists of two stepped down phases: inpatient 
(1 month) and outpatient (the following 12 months). During 
the inpatient phase, participants attend an intensive four 
week and medically-managed program for weight reduction 
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nutritionally balanced diet tailored to the individual after 
consultation with a dietitian (energy intake around 80% of 
the basal energy expenditure estimated according to the Har-
ris-Benedict equation and a  macronutrient composition of 
16% proteins, 25% fat and 59% carbohydrates). Further-
more, they receive nutritional counseling provided by a dieti-
tian, brief psychological counseling provided by a clinical 
psychologist and have physical activity training provided by 
a physiotherapist.  
Nutritional rehabilitation program aims to improve and 
promote change in eating habits and consists of both indi-
vidual sessions (dietary assessment, evaluation of nutrient 
intake and adequacy, nutritional status, anthropometric, eat-
ing patterns, history of overweight, readiness to adopt 
change) and group sessions (45 minutes each twice a week) 
including: information on obesity and related health risks, 
setting of realistic goals for weight loss, healthy eating in 
general, general nutrition and core food groups, weight man-
agement and behavior change strategies for preventing re-
lapse). 
Psychological counseling is provided once a week both 
individually and in group setting. Individual sessions, lasting 
45 minutes each, are mainly based on the cognitive-
behavioral approach described by Cooper and Fairburn [29] 
and emphasize the techniques of self-monitoring, goal set-
ting, time management, prompting and cueing, problem solv-
ing, cognitive restructuring, stress management and relapse 
prevention. Group sessions (small groups of 5/6 persons), 
lasting 1 hour each, focus on issues such as motivation to 
change, assertiveness, self-esteem, self-efficacy and coping. 
Physical activity takes place once a day except for week-
end and consists of group programs (20 individuals) based 
on postural gymnastics, aerobic activity and walks in the 
open. Patients with specific orthopedic complications carry 
out individual activities planned by physiotherapists and 
articulated in programs of physical therapy, assisted passive 
and active mobilization and isokinetic exercise. 
Low to moderate weight losses are expected at the end of 
the inpatient phase, but notably weight loss is not the pri-
mary goal of the inpatient program and each patient is made 
clear about this point at the very beginning of the treatment. 
Developing a sense of autonomy and competence are the 
primary purposes of the inpatient interventions. Patients are 
afforded the skills and tools for change and are supported in 
assigning positive values to healthy behaviors and also in 
aligning them with personal values and lifestyle patterns.  
In the last week of hospitalization, just before discharge 
from the hospital, participants allocated to the TECNOB 
program are instructed for the out-patient phase. Firstly, they 
receive a multisensory armband (SenseWear® Pro2 Arm-
band), an electronic tool that enables automated monitoring 
of total energy expenditure (calories burned), active energy 
expenditure, physical activity duration and levels (METs). 
Patients are instructed to wear this device on the back of the 
upper arm and to record data for 36 hours every two weeks 
in a free-living context. The Armband holds up to 12 days of 
continuous data which the outpatients are instructed to 
download into their personal computer and to transmit online 
to a web-site specifically designed for data storing. Outpa-
tients are also told that they can review their progress using 
the InnerView® Software which analyzes and organizes data 
into graphs and reports. Secondly, participants are instructed 
to use the TECNOB web-platform, an interactive web-site 
developed by TELBIOS S.P.A. (http://www.telbios.it). The 
TECNOB web-platform supports several functions and de-
livers many utilities, such as questionnaires, an animated 
food record diary, an agenda and a videoconference virtual 
room. In the “questionnaires” section, patients submit data 
concerning weight and glycated hemoglobin. In the “food 
record diary” participants submit actual food intake day by 
day through the selection of food images from a comprehen-
sive visual database provided by METEDA S.P.A. 
(http://www.meteda.it). The same procedure is also possible 
through a software called METADIETA (Meteda s.p.a.) pre-
viously installed on the outpatients’ mobile phones before 
discharge. Through the mobile phones outpatients maintain 
the contact with the dietitian who regularly sends them SMS 
containing syntax codes that METADIETA, the software 
previously installed into the outpatients’ mobile phones, uses 
in order to visually display the food choices (frequency and 
portions) outpatients have to adhere according to dietary 
prescriptions. By this way, outpatients can keep a food re-
cord diary allowing comparisons between current eating and 
the recommended hypocaloric diet along the whole duration 
of the program. The “agenda” allows the patients to remem-
ber the videoconference appointments with the clinicians and 
the days when to fill in the questionnaires. Moreover, the 
patients can use the “memo” space to note down any impor-
tant event occurred to him/her in the previous week/month. 
Indeed, some research indicates that changes in behavior 
(eating and exercise) often follow discrete moments [30]. 
Life events can lead to weight loss but also to weight gain 
and qualitative research shows that it is not the event per se 
that results in behavior change but the ways in which this 
event is appraised and interpreted by the individual [31]. The 
clinical psychologist has thus the opportunity to discuss with 
the outpatients about the significant events reported in the 
“memo” space during the videoconference sessions and cog-
nitively reconstruct dysfunctional appraisals in functional 
ways. Finally, outpatients are instructed to use the videocon-
ference tool. Thanks to this medium, they receive nutritional 
and cognitive-behavioral tele-counseling with the dietitian 
and the clinical psychologist who attended the patients inside 
the hospital. In particular, just after discharge, participants 
have 6 videoconference contacts with both clinicians along 3 
months. From the 3rd to the 6th month sessions are sched-
uled every 30 days and then even more spaced up to an in-
terval of 60 days. During tele-sessions, clinicians (psycholo-
gist and dietitian) test the outpatients’ progress, their mood, 
the maintenance of the “good alimentary and physical activ-
ity habits”, the loss/increase of weight and ask about critical 
moments, especially those ones reported on the “memo” 
web-space. In particular, tele-sessions with the clinical psy-
chologist aim to consolidate strategies and abilities acquired 
during the in-patient phase, to improve self-esteem and self-
efficacy, to support motivation, to prevent relapse and to 
provide problem-solving and crisis counseling. On the other 
hand, dietitian assesses adherence and compliance to dietary 
therapy with a special focus on normal eating behavior, suf-
ficient fluid intake, hunger and fullness regulation, appropri-
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eating, and addresses critical points such as plateau in weight 
loss or lack of readiness to improve dietary habits. 
In addition to videoconference, outpatients can further 
contact clinicians by e-mail. Indeed, each patient is given the 
possibility to join his clinician beyond the established video-
conference contacts in case of urgency or emergency. Ac-
cording to the e-message’s content, clinicians choose the 
most appropriate format for delivering feedback among e-
mail or telephone. In order to avoid excessive dependence 
and to contain costs, a maximum number of 1 not scheduled 
contact a week is established a priori.  
Great relevance is given to the clinicians-patient relation-
ship as an important medium and vehicle of change [32]. 
After discharge, out-patients begin to experience the auton-
omy and competence to change they develop during the in-
patient phase and inevitably face resistances and barriers. 
Thanks to videoconferences, outpatients are supported by the 
clinicians who attended them during the inpatient phase in 
exploring resistances and barriers they experience and in 
finding functional pathways to cope. Furthermore, out-
patients are helped to experience mastery in terms of the 
health behavior change that needs to be engaged. 
Measurements 
Primary outcome measure of the randomized trial is 
weight change in kilograms. Secondary outcome measures 
are energy expenditure, glycated hemoglobin, binge eating, 
self-efficacy in eating and weight control, body satisfaction, 
healthy habits formation, disordered eating-related behaviors 
and cognitions, psychopathological symptoms and weight-
related quality of life. However, in this paper only weight 
and disordered eating-related behaviors and cognitions (EDI-
2) data were analyzed and reported. Weight were assessed 
with the participant in lightweight clothing with shoes re-
moved on a balance beam scale. The EDI-2 is a widely used, 
standardized, self-report measure of psychological symptoms 
commonly associated with anorexia nervosa, bulimia ner-
vosa and other eating disorders. The EDI-2 does not yield a 
specific diagnosis of eating disorder. It is aimed at the meas-
urement of psychological traits or symptom clusters pre-
sumed to have relevance to understanding and treatment of 
eating disorders. The EDI-2 consists of 11 subscales derived 
from 91 items. Three of the subscales were designed to as-
sess attitudes and behaviors concerning eating, weight and 
shape (Drive for Thinness, Bulimia, Body Dissatisfaction) 
and the remaining eight ones tapped more general constructs 
or psychological traits clinically relevant to eating disorders 
(Ineffectiveness, Perfection, Interpersonal Distrust, Intero-
ceptive Awareness, Maturity Fears, Asceticism, Impulse 
Regulation and Social Insecurity) [33, 34]. 
Follow-up EDI-2 data were self-reported by mailed ques-
tionnaires.  
Statistical Analysis 
Between-group differences in weight and glycated he-
moglobin were examined at all time-points using the Mann-
Whitney nonparametric test due to small sample and viola-
tion of parametric assumptions. A completers analysis was 
performed for any time-points (n=34 at 3 months, n=21 at 6 
months and n=13 at 12 months). Changes over time were 
examined using the Wilcoxon test. Chi-square test was used 
for categorical variables. 
All analyses were performed using the Statistical Pack-
age for Windows version 11 for the Social Sciences (SPSS, 
Chicago).  
RESULTS 
Baseline Characteristics 
At baseline, there were no significant differences be-
tween groups in age, weight and percentage of females. 
However, statistically significant differences were found in 
some EDI-2 scales: Drive for Thinness (p=0,038), Ineffec-
tiveness (p=0,049), Interoceptive awareness (p=0,003), Im-
pulse regulation (p=0,045) and Social Insecurity (p=0,001) 
(see Table 1).  
Weight Change 
There were no significant differences between groups in 
weight at discharge and at 3-month follow-up. No significant 
difference was found even in weigh change and percentage 
of weight loss from baseline to discharge and to 3-month 
follow-up (Table 2 and Table 3). At 6 and 12 months, com-
pleters analysis of weight data did not show any significant 
difference between groups (Table 2 and Table 3). Moreover, 
no significant association between groups and number of 
Table 1.  Baseline Characteristics by Treatment Group 
Characteristics  TECNOB (n = 17)  Control (n = 17)  Significance of Difference 
Age, y   49 (46-57,5)  54 (49-60)  ns 
Female  31,3% 64,7%  ns 
Weight, Kg   124 (105,6-140,8)  110 (94,9-127,6)  ns 
EDI-2 Drive for Thinness   4 (1,5-7)  8 (3-12,5)  0,038 
EDI-2 Ineffectiveness   2 (1-4,5)  5 (2-7,5)  0,049 
EDI-2 Interoceptive awareness  1 (0-2)  3 (2-10)  0,003 
EDI-2 Impulse regulation  0 (0-2)  2 (0-6)  0,045 
EDI-2 Social Insicurity  3 (1-4)  6 (3,5-8,5)  0,001 
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patients who lost 5% or more of initial body weight was 
found at any time-point. 
Given the lack of any significant between-group differ-
ence, patients were pooled in one group and weight change 
over time was examined by Wilcoxon nonparametric test. 
Within-group analyses revealed significant reductions of 
initial weight at discharge (-5,9 kg, p<0,000), at 3 months  
(-8,2 kg, p<0,000) and at 6 months (-7,6 kg, p=0,002). Re-
duction of baseline weight at 12 months was not statistically 
significant (-6,9 kg, p=0,136).  
Eating-Related Behaviors and Cognitions (EDI-2) 
Apart from the variables whose baseline median scores 
were shown to be statistically different between groups, a 
significant difference was found in Interpersonal distrust at 
12 months (p=0,02). Patients in the control group had a higher 
median score compared with the TECNOB group (7 vs. 2).  
DISCUSSION 
This interim analysis of the first data from the TECNOB 
study did not reveal any significant difference between the 
TECNOB program and a control condition in weight change 
at 3, 6 and 12 months. Within-group analysis showed sig-
nificant reductions of initial weight at all time-points but not 
at 12-month follow-up. The median percentage of initial 
weight loss for the whole sample was -5,1 kg (-6,6 to -3,7) at 
discharge from the hospital. Given the health benefits asso-
ciated with such weight reductions [35, 36], the inpatient 
program was effective in decreasing weight but notably 
weight loss was not the primary goal of the in-patient treat-
ment. Beyond medical care, structured diet and physical ex-
ercise, obese inpatients received education, professional 
counseling and skills training from physicians, dieticians, 
psychologists and physical trainers along the 1-month hospi-
talization. Empowerment, life-style modification and moti-
vation improvement were the main purposes. Indeed, the 
great challenge all weight-loss programs have to face is 
weight-loss maintenance. In this ad interim study, the me-
dian percentage of weight loss from baseline was -7,4 kg   
(-10,1 to -5,2) at 3-month follow-up. On average, partici-
pants maintained the weight they achieved at the end of the 
inpatient program and reached further reductions. However, 
Table 2.  Medians, Quartiles and Statistical Significance for Between-Group Differences in weight (kg.) at all Time-Points 
  Group N  Median  Quartiles  p* 
Control 17  110  95-127,6 
Baseline Weight 
TECNOB 17  124  105,6-140,8 
0,076 
Control 17  105  89-121,1 
Weight at discharge 
TECNOB 17  116  101,1-133,5 
0,065 
Control 17  105  87,4-122 
Weight at 3 months 
TECNOB 17  116  99,6-129,3 
0,085 
Control 12  104,4  91,4-108 
Weight at 6 months 
TECNOB 9  113  94,2-125,5 
0,24 
Control 9  103,3  88,5-114,5 
Weight at 12 months 
TECNOB 3  131 88-148 
0,405 
* Mann-Whitney nonparametric test. 
 
Table 3.  Medians, Quartiles and Statistical Significance for Between-Group Differences in Percentage of Weight Loss (kg.) from 
Baseline at all Time-Points 
  Group N Median  Quartiles  p* 
Control  17  -4,9  -7,1 to -3,7 
Percentage of weight loss at discharge 
TECNOB  17  -5,2  -6,6 to -3,7 
0,823 
Control  17  -7,9  -10,8 to -2,6 
Percentage of weight loss at 3 months 
TECNOB  17  -6,9  -9,6 to -5,4 
0,77 
Control  12  -7,3  -12,1 to 0 
Percentage of weight loss at 6 months 
TECNOB  9  -6,9  -10,7 to -3,2 
0,943 
Control  9  -4,1  -15,3 to 3 
Percentage of weight loss at 12 months 
TECNOB  3  -6,2  -10,6 to 16,7 
0,644 
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completers analysis of data collected at 6 and 12 months 
showed that participants regained back part of the weight 
loss and the difference between weight at baseline and at 12-
month follow-up was no more statistically significant. Nota-
bly, sample sizes at 6 and 12 months are small (n=21 and 
n=12 respectively) due to the ongoing status of the study and 
these results may be unreliable. 
Differences in eating-related behaviors and cognitions 
(EDI-2) were also examined. At baseline, the control group 
showed higher scores in many EDI-2 scales, i.e. Drive for 
Thinness, Ineffectiveness, Interoceptive awareness, Impulse 
regulation and Social Insecurity, compared with the TEC-
NOB group. Notably, these groups included selected partici-
pants (those patients that have come through at least the 3-
month follow-up) and such statistically significant differ-
ences were not found when the original groups were com-
pared. Control group showed higher scores also in Interper-
sonal distrust at 12 months. However, this result has to be 
seen with caution because of the few patients (n=12) who 
have achieved the end of the program at present. 
In conclusion, these ad interim findings seem not to sup-
port the effectiveness of the TECNOB program over a con-
trol condition. Notably, this kind of data analysis (ad interim 
analysis) is underpowered and results we obtained may be 
unreliable, in particular at 6 and 12 months. However, we 
gained a significant insight into an important component of 
the study design, i.e. the 1-month inpatient program. The 
effect that such uncontrolled factor had on weight loss was 
very high and probably overwhelmed the effect of the TEC-
NOB intervention. Much statistical power is thus necessary 
to enhance the chance to detect the effect of the TECNOB 
program. According to our a-priori sample size calculation 
[27], 64 participants per group are needed to detect a differ-
ence of 3 kg between the groups at 12 months. Also time is 
probably a key factor for the detection of the TECNOB ef-
fect. Seemingly, the inpatient program has a very high effect 
in the first months after discharge but such effect may reduce 
in the long term. A 12-month follow-up is probably suffi-
cient to detect the TECNOB effect over and above the weak-
ened effect of the inpatient program. We will know if our 
predictions are correct in at least one year.  
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